The genetics of PSP/CBD and FTDP-17

被引：0
|
作者：
Hutton, M [1 ]
机构：
[1] Mayo Clin, Jacksonville, FL 32224 USA
来源：
MOVEMENT DISORDERS | 2002年 / 17卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1402 / 1403
页数：2
相关论文
共 50 条
  • [21] Brain acetylcholinesterase activity in FTDP-17 studied by PET
    Hirano, S
    Shinotoh, H
    Kobayashi, T
    Tsuboi, Y
    Wszolek, ZK
    Aotsuka, A
    Tanaka, N
    Ota, T
    Fukushi, K
    Tanada, S
    Irie, T
    NEUROLOGY, 2006, 66 (08) : 1276 - 1277
  • [22] MAPT mutation associated with frontotemporal dementia and parkinsonism (FTDP-17)
    Haussmann, Robert
    Wysocki, Marek
    Brandt, Moritz D.
    Hermann, Andreas
    Donix, Markus
    INTERNATIONAL PSYCHOGERIATRICS, 2017, 29 (05) : 869 - 871
  • [23] Effects of FTDP-17 mutations of tau on the functions of tau.
    Licher, F
    Barghorn, S
    von Bergen, M
    Zheng-Fischhofer, Q
    Ackmann, M
    Wiech, H
    Mandelkow, EM
    Mandelkow, E
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 374A - 374A
  • [24] A novel deletion in progranulin gene is associated with FTDP-17 and CBS
    Benussi, Luisa
    Binetti, Giuliano
    Sina, Elena
    Gigola, Lara
    Bettecken, Thomas
    Meitinger, Thomas
    Ghidoni, Roberta
    NEUROBIOLOGY OF AGING, 2008, 29 (03) : 427 - 435
  • [25] Sleep Architecture Changed Without RBD in Patients With FTDP-17
    Liu, Jia
    Zhan, Shuqin
    Huang, Chaoyang
    Liu, Yang
    Liu, Lin
    Wu, Liyong
    Wang, Yuping
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2018, 14 (10): : 1735 - 1739
  • [26] Gene expression and proteomic profiles of FTDP-17: Preliminary analyses
    Murrell, Jill
    Schweitzer, Kelly
    McClintick, Jeanette
    Decker, Emily
    Spina, Salvatore
    Wang, Mu
    Edenberg, Howard
    Ghetti, Bernardino
    BRAIN PATHOLOGY, 2006, 16 : S45 - S45
  • [27] Partial Deletion of the MAPT Gene: A Novel Mechanism of FTDP-17
    Rovelet-Lecrux, Anne
    Lecourtois, Magalie
    Thomas-Anterion, Catherine
    Le Ber, Isabelle
    Brice, Alexis
    Frebourg, Thierry
    Hannequin, Didier
    Campion, Dominique
    HUMAN MUTATION, 2009, 30 (04) : E591 - E602
  • [28] Biochemical and immunocytochemical study on FTDP-17 - From patients to mice
    Miyasaka, T
    Tatebayashi, Y
    Morishima, M
    Takashima, A
    Ihara, Y
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 59P - 59P
  • [29] Olfactory dysfunction in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
    Robowski, P.
    Slawek, J.
    Narozanska, E.
    Schinwelski, M.
    Sitek, E. J.
    Kucharska, W.
    Brockhuis, B.
    Lass, P.
    Wieczorek, D.
    Dubaniewicz, M.
    Jasinska-Myga, B.
    Baker, M. C.
    Rademakers, R.
    Wszolek, Z. K.
    MOVEMENT DISORDERS, 2009, 24 : S174 - S175
  • [30] Atypical and slowly progressive FTDP-17 caused by MAPT p. R406W mutations - similarities to AD and PSP
    Ygland, E.
    van Westen, D.
    Englund, E.
    Rademakers, R.
    Wszolek, Z.
    Nilsson, K.
    Nilsson, C.
    Hansson, O.
    Gustafson, L.
    Puschmann, A.
    MOVEMENT DISORDERS, 2017, 32
12345